Dergiler / Namık Kemal Tıp Dergisi / 2026 / Cilt: 7 Sayı: 1

Assessment of Methotrexate Efficacy in The Treatment of Ectopic Pregnancy

Mehmet Obut(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-6925-4784
Hanifi Bademkıran(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-9350-582X
Sedat Akgöl(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-8609-3049
Bekir Kahveci(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-8729-1669
İhsan Bağlı(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0002-3195-9164
Süleyman Cemil Oğlak(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-7634-3008
Mehmet Şukru Budak(DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ)0000-0001-7328-4188
Sayfa
25–30
Yayın Tarihi
2019-04-22
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion : In our study, success rates in patients with EP treated with MTX were 80% after a single dose and as high as 90.7% when a second dose was added.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:ABSTRACT Objective : Our aim in this study was to assess efficacy of single-dose methotrexate (MTX) as medical treatment for ectopic pregnancy (EP) by evaluating the results of patients given this treatment.
📊
Temel Bulgular & Veri:Materials and Methods: Between September 2016 and August 2017, the treatment outcomes of EP cases treated with MTX at Gazi Yaşargil Training and Research Hospital of Health Sciences University were evaluated retrospectively.
💡
Sonuç & Katkı:Conclusion : In our study, success rates in patients with EP treated with MTX were 80% after a single dose and as high as 90.7% when a second dose was added.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Ectopic pregnancy · medical treatment · methotrexate

Özet

ABSTRACT Objective : Our aim in this study was to assess efficacy of single-dose methotrexate (MTX) as medical treatment for ectopic pregnancy (EP) by evaluating the results of patients given this treatment. Materials and Methods: Between September 2016 and August 2017, the treatment outcomes of EP cases treated with MTX at Gazi Yaşargil Training and Research Hospital of Health Sciences University were evaluated retrospectively. Results: In total, 126 cases treated for EP were evaluated and 65 cases were included in the study. In cases administered a single dose of MTX, the success rate was 80%, the failure rate was 13.8%, and the emergency surgery rate was 6.2%. The overall success rate of the medical treatment was 90.7% for a second dose of MTX. An unsuccessful result was considered as less than a 15% reduction in the beta-human chorionic gonadotropin (β-hCG) level between 4 and 7 days after single dose MTX administration. In all cases, the rate of emergency surgery after treatment was 9.3%. Conclusion : In our study, success rates in patients with EP treated with MTX were 80% after a single dose and as high as 90.7% when a second dose was added.

🔖

Bu Makaleye Atıf Yap

Obut, M., Bademkıran, H., Akgöl, S., Kahveci, B., Bağlı, İ., Oğlak, S. C., Budak, M. Ş. (2019). Assessment of Methotrexate Efficacy in The Treatment of Ectopic Pregnancy. Namık Kemal Tıp Dergisi, Cilt: 7 Sayı: 1, 25–30. https://ajindex.com/articles/1295089

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (25)

  1. REFERENCES1. Kirk E, Bourne T. Ectopic pregnancy. Obstet Gynecol Reprod Med 2011; 21:207–11
  2. Stovall TG, McCord ML. Early pregnancy lost and ectopic pregnancy. In: Berek JS, Adashi EY, Hillard PA, editors. Novak’s Gynecology (12th ed). Maryland: Williams&Wilkins; 1996. p. 487–523.
  3. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GDF, Clark SL. Williams Obstetrics (20th ed). New Jersey: Prentice Hall International, Inc.; 1997. p. 607–34.
  4. Condous G. The management of early pregnancy complications. Best Pract Res Clin Obstet Gynaecol 2004; 18:37–57.
  5. Ackerman TE, Levi CS, Dashefsky SM. Interstitial line: sonographic finding in interstitial (cornual) ectopic pregnancy. Radiology 1993; 189:83–7.
  6. Schwartz RO, Di Pietro DL. B-hCG as a diagnostic aid for suspected ectopic pregnancy. Obstet Gynecol 1980; 56:197-203.
  7. Lawlor HK, Rubin BJ. Early diagnosis of ectopic pregnancy. West J Med 1993; 159:195–9.
  8. Mayor S. Early diagnosis of ectopic pregnancy is essential to reduce deaths, says guideline. BMJ 2016; 355:i5954.
  9. Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol 2003; 101:778–84.
  10. Sowter MC, Farquhar CM, Petrie KJ, Gudex G. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. BJOG 2001; 108:192-203.
  11. Seeber BE, Barnhart KT (2006) Suspected ectopic pregnancy. Obstet Gynecol 107:399–413.
  12. Stovall TG, Ling FW, Gray LA. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 1991; 77:754-7.
  13. Buster JE, Carson SA. Ectopic pregnancy; new advances in diagnosis and treatment. Curr Opinion Obstet Gynecol 1995; 7:168–76.
  14. Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician 2005; 72:1704-14.
  15. Rana P, Kazmi I, Singh R, Afzal M, Al-Abbasi FA, Aseeri A, Singh R, Khan R, Anwar F. Ectopic pregnancy: a review. Arch Gynecol Obstet 2013; 288:747-57.
  16. Nyberg DA, Filly RA, Laing FC, Mack LA, Zarutskie PW. Ectopic pregnancy. Diagnosis by sonography correlated with quantitative HCG levels. J Ultrasound Med 1987; 6:145–50.
  17. Stika CS. Methotrexate: the pharmacology behind medical treatment for ectopic pregnancy. Clin Obstet Gynecol 2012; 55:433-9.
  18. Kusgoz AG, Aka N, Coskun ADE, Kose G, Tufekcı EC, Vural F. Risk factors and treatment modalities in ectopic pregnancy cases. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi 2017; 57:1–5.
  19. Shalev E, Peleg D, Tsabari A, Romano S, Bustan M. Spontaneous resolution of ectopic tubal pregnancy: natural history. Fertil Steril 1995; 63:15–9.
  20. Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. Am Fam Physician 2005; 72:1707–1714.
  21. Aybatlı A, Kaplan PB, Alicik M, Sayın NC, Yuce MA. Single dose methotrexate in treatment of ectopic pregnancy: Review of 32 cases. Balkan Med J 2011; 28: 10–3
  22. Yenen MC, Dede M, Göktolga Ü, Küçük T, Alanbay İ, Pabuçcu R. Ektopik gebelikte risk faktörleri. Gülhane Tıp Dergisi, 2003; 45:244–8.
  23. Butts S, Sammel M, Hummel A, Chittams J, Barnhart K. Risk factors and clinical features of recurrent ectopic pregnancy: a case control study. Fertil Steril, 2003; 80: 1340–4.
  24. Karaer A, Avşar F A, Batıoğlu S. Risk factors for ectopic pregnancy: a case control study. ANZJOG, 2006; 46:521–7.
  25. Bacanakgil H, Unal F, Celik S, Bilgi A, Boran B. The results of risk factors and clinical findings of ectopic pregnancy. İstanbul Tıp Dergisi 2008; 4:182–6.